A pharmaceutical company GMP compliance check does not pass the disagreement to resume production.

Has been withdrawn GMP certificate After inquiry found that the company due to internal management confusion, quality management system can not operate effectively, a serious departure from the requirements of the drug GMP, drug production there is a serious quality risk, in 2016 was withdrawn the drug GMP certificate.
In 2017, the Anhui Food and Drug Administration issued the Notice on the Issue of the 2017 Drug GMP Tracking Flight Inspection Work Programme (No. 28 of the Pharmaceutical Supervision and Chemical Technology (2017), and Wuhu Boying Pharmaceutical Technology Co., Ltd. was included in the list of enterprises with more "warning letters" and defective items.
July 11, 2018, Anhui Food and Drug Administration issued a notice on the withdrawal of the GMP certificate of discontinued enterprises (No. 58 of 2018), the provincial bureau in the organization of drug production enterprises flight inspection process, found that 14 enterprises are in a state of long-term shutdown, and not fully equipped with production conditions, Wuhu Boying Pharmaceutical Technology Co., Ltd. is also included in the list.
.